Cynosure Group’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,789
Closed -$495K 369
2025
Q4
$495K Buy
+2,789
New +$465K 0.05% 185
2020
Q2
Sell
-7,597
Closed -$258K 45
2020
Q1
$258K Sell
7,597
-1,340
-15% -$63.1K 0.18% 58
2019
Q4
$457K Hold
8,937
0.24% 42
2019
Q3
$381K Sell
8,937
-3,160
-26% -$135K 0.21% 48
2019
Q2
$530K Buy
+12,097
New +$540K 0.24% 47

Other funds holding MS

Cynosure Group's MS Position: Q1 2026 in Review

Cynosure Group sold out of Morgan Stanley (MS) in Q1 2026, closing a stake of 2,789 shares — an estimated $495K sold.

Cynosure Group first reported a position in MS in Q2 2019 and held it in 5 quarters. The position peaked at $530K in Q2 2019. 2,489 funds tracked by Wall St. Rank hold MS as of Q1 2026.

  • Cynosure Group reported no remaining Morgan Stanley position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 2,789 Morgan Stanley shares in Q1 2026, an estimated $495K.
  • Cynosure Group first reported a position in Morgan Stanley in Q2 2019 and held it in 5 quarters.
  • Cynosure Group's Morgan Stanley position peaked at $530K in Q2 2019.
  • 2,489 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.